- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2012
- Public Summary Document (PSD) March 2012 PBAC Meeting - PDF
Imatinib – March 2012
Imatinib, tablets, 100 mg and 400 mg (as mesylate), Glivec®
Last updated
8 November 2023